Clinical trial · Interventional
Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial
Feasibility of an RCT to Investigate the Efficacy of Ice Plant Intensive Cream for the Prevention of Hand-foot Syndrome in Patients With Breast Cancer Receiving Therapy With Doxorubicin and/or Docetaxel: Pilot Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Hand-Foot Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ice Plant Intensive Cream plus Standard Care | Other | — | UNRESOLVED |
| Standard Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Ice Plant Intensive Cream plus Standard Care
- description
- This group receives a 30-minute nursing consultation on the standard treatment and on the use of the Ice Plant Intensive Cream for the prevention of hand-foot syndrome.
- interventionNames
- Other: Ice Plant Intensive Cream plus Standard Care
- type
- ACTIVE_COMPARATOR
- label
- Standard Care
- description
- This group receives a 30-minute nursing consultation on the standard treatment for the prevention of hand-foot syndrome.
- interventionNames
- Other: Standard Care
Primary outcomes (5)
- measure
- Number of patients that can be recruited in a 9 months time period
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Breast cancer patients * Therapy with Doxorubicin and/or Docetaxel * Karnofsky performance status scale \> 80 * Informed consent Exclusion Criteria: * Patients with previous skin disease and/or polyneuropathy * Intolerance or allergic reaction on at least one ingredient of Ice Plant Intensive Cream * Already receiving chemotherapy * Usage of Ice Plant Intensive Cream before trial * Severe physical or psychological illness due to which the patient is not able to participate in the study * Lack of German language skills
References
Publications (0)
Data not yet available